Chorionic Villus Sampling (CVS): A Key Diagnostic Tool

Prenatal care has evolved dramatically over the past few decades, offering expectant parents more options than ever to understand their baby’s health before birth. Among the most valuable tools available is chorionic villus sampling, a diagnostic procedure that can detect genetic conditions early in pregnancy. For nursing students and healthcare professionals, understanding this procedure is essential for providing comprehensive care and counseling to pregnant individuals facing difficult decisions.

What is chorionic villus sampling? 🔗

Chorionic villus sampling is a prenatal diagnostic test performed between 10 and 13 weeks of pregnancy to detect chromosomal abnormalities and genetic disorders in a developing fetus. Unlike screening tests that only estimate risk, CVS provides definitive diagnostic results by analyzing actual fetal genetic material.

The procedure involves taking a small sample of tissue from the placenta, specifically from structures called chorionic villi. These tiny finger-like projections contain the same genetic material as the fetus, making them ideal for genetic testing. The sample can reveal whether the baby has conditions like Down syndrome, cystic fibrosis, sickle cell disease, or Tay-Sachs disease.

How the procedure works 🔗

There are two approaches to performing CVS, and the choice depends largely on placental location and provider preference.

Transabdominal CVS 🔗

In the transabdominal approach, which is performed under continuous ultrasound guidance, the healthcare provider cleans the abdomen with an antiseptic solution and may apply local anesthetic. A thin needle is then inserted through the abdominal wall and uterus into the placenta. Using a syringe, the provider collects a small sample of chorionic villi tissue. The entire procedure typically takes 30 to 45 minutes, though the actual sampling takes just a few minutes.

Transcervical CVS 🔗

The transcervical method involves inserting a thin, flexible catheter through the vagina and cervix to reach the placenta. Using ultrasound guidance, the provider moves the catheter to the placenta and gently suctions a tissue sample. Some women report this feels similar to a Pap smear, while others experience cramping during the procedure.

Regardless of the method used, the tissue sample is sent to a laboratory for genetic analysis. Results typically return within one to two weeks, though preliminary findings may be available in as few as two to four days.

Who should consider CVS? 🔗

CVS is not a routine test for all pregnancies. Healthcare providers typically recommend it for individuals at higher risk of having a baby with genetic abnormalities. Risk factors include being 35 years or older, as maternal age significantly increases the likelihood of chromosomal disorders like Down syndrome.

Other candidates for CVS include those with a family history of genetic conditions, parents who are known carriers of genetic disorders, individuals with abnormal prenatal screening results, or those who have previously had a child with a genetic condition. The American College of Obstetricians and Gynecologists recommends that all pregnant women, regardless of age, be offered prenatal assessment for aneuploidy through either screening or diagnostic testing.

CVS versus amniocentesis: Understanding the differences 🔗

When discussing prenatal diagnostic testing, CVS and amniocentesis often come up together. While both procedures can diagnose genetic conditions, they differ in several important ways.

Timing 🔗

The most significant difference is timing. CVS can be performed between 11 and 13 weeks of pregnancy, while amniocentesis is typically done after week 16. This earlier timing with CVS gives families more time to make informed decisions and access earlier options if termination is considered.

What each test can detect 🔗

Both procedures are highly accurate for detecting chromosomal abnormalities and genetic disorders. However, there’s one key limitation with CVS: it cannot detect neural tube defects like spina bifida. Amniocentesis can screen for these conditions, which is why women who undergo CVS may need additional testing, such as an alpha-fetoprotein blood test between 16 and 18 weeks, to screen for neural tube defects.

Procedure-related risks 🔗

Current research indicates that both procedures carry a very low risk of pregnancy loss, estimated at less than 0.3%. While earlier studies suggested CVS might carry slightly higher risks than amniocentesis, recent evidence shows comparable safety profiles when performed by experienced providers. The risk of miscarriage has decreased significantly with improved ultrasound technology and provider expertise.

Special considerations 🔗

One unique aspect of CVS is the possibility of detecting confined placental mosaicism, which occurs in about one to two percent of cases. This happens when chromosomal abnormalities are present in the placenta but not in the fetus itself. When mosaicism is detected, amniocentesis is usually recommended to clarify whether the abnormality affects the baby.

Benefits of early diagnosis 🔗

The primary advantage of CVS is the ability to obtain diagnostic information early in pregnancy. This early timing provides several benefits. First, it allows more time for decision-making and counseling. Families can meet with genetic counselors, research the diagnosed condition, and consider all available options without the pressure of advanced pregnancy.

Second, early diagnosis enables better pregnancy management. If a genetic condition is detected, healthcare teams can plan specialized care, arrange for delivery at facilities equipped to handle the baby’s specific needs, and coordinate with pediatric specialists before birth. In some cases, certain conditions can even be treated before the baby is born.

Third, knowing about a genetic condition early helps parents prepare emotionally and practically for their baby’s arrival. They can connect with support groups, learn about the condition, and make necessary arrangements for their family.

Understanding the risks 🔗

While CVS is generally safe, it’s important to understand the potential complications. The most concerning risk is pregnancy loss, though this occurs in less than one percent of procedures when performed by experienced providers. Other risks include infection, bleeding, and amniotic fluid leakage, all of which are rare.

Some women experience cramping or spotting after the procedure, which typically resolves within a few hours. Vaginal spotting has been reported in up to 32% of women and is more common after transcervical CVS. Patients should contact their healthcare provider immediately if they experience heavy bleeding, fever, severe cramping, or fluid leakage after the procedure.

There has been concern about limb defects associated with CVS, but research shows this risk is extremely low and primarily associated with procedures performed before 10 weeks of gestation. The World Health Organization estimates the risk of limb defects at approximately six per 10,000 cases, similar to the general population risk.

The importance of genetic counseling 🔗

Before undergoing CVS, patients typically meet with a genetic counselor or maternal-fetal medicine specialist. These professionals discuss the risks and benefits of the procedure, explain what conditions can be detected, and help families understand what the results might mean for their pregnancy. This counseling is crucial for informed decision-making.

After receiving results, genetic counseling becomes equally important. If results show a genetic abnormality, counselors help families understand the condition’s implications, discuss available resources, and explore all options. Even when results are normal, counselors can address any remaining concerns and discuss the limitations of the testing.

Making the decision 🔗

Choosing whether to undergo CVS is deeply personal. Some families want as much information as possible about their baby’s health, while others prefer not to pursue invasive testing. There is no right or wrong choice-only what feels right for each individual family based on their values, beliefs, and circumstances.

Factors to consider include the level of risk for genetic conditions, how the information would influence pregnancy management or decision-making, concerns about procedure-related risks, and personal values about prenatal testing. Healthcare providers can offer guidance, but the final decision always rests with the pregnant individual and their partner.

What do you think? How might advances in prenatal testing technology continue to shape the conversations nurses have with expectant parents? What role should healthcare professionals play in supporting families through the complex emotions that often accompany prenatal diagnostic testing decisions?

References

1. https://medlineplus.gov/lab-tests/chorionic-villus-sampling-cvs/
2. https://www.ncbi.nlm.nih.gov/books/NBK563301/
3. https://my.clevelandclinic.org/health/diagnostics/4028-chorionic-villus-sampling-for-prenatal-diagnosis
4. https://www.marchofdimes.org/find-support/topics/planning-baby/chorionic-villus-sampling
5. https://utswmed.org/medblog/cvs-amniocentesis-faqs/
6. https://familydoctor.org/prenatal-diagnosis-amniocentesis-and-cvs/